Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) EBT Margin (2019 - 2025)

Revolution Medicines has reported EBT Margin over the past 6 years, most recently at 2976.77% for Q4 2025.

  • Quarterly results put EBT Margin at 2976.77% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 136301.33% (changed N/A YoY), and the annual figure for FY2023 was 3798.71%, down 309457.0%.
  • EBT Margin for Q4 2025 was 2976.77% at Revolution Medicines, down from 2670.69% in the prior quarter.
  • Over the last five years, EBT Margin for RVMD hit a ceiling of 2670.69% in Q3 2025 and a floor of 21724.26% in Q4 2023.
  • Median EBT Margin over the past 4 years was 760.72% (2022), compared with a mean of 2754.52%.
  • Biggest five-year swings in EBT Margin: surged 261449bps in 2022 and later plummeted -2135485bps in 2023.
  • Revolution Medicines' EBT Margin stood at 556.83% in 2021, then surged by 34bps to 369.41% in 2022, then plummeted by -5781bps to 21724.26% in 2023, then surged by 86bps to 2976.77% in 2025.
  • The last three reported values for EBT Margin were 2976.77% (Q4 2025), 2670.69% (Q3 2025), and 21724.26% (Q4 2023) per Business Quant data.